Screening of an FDA-Approved Library for Novel Drugs against <i>Y. pestis</i>
<i>Yersinia pestis</i> is a Gram-negative pathogen that causes plague, a devastating disease that kills millions worldwide. Although plague is efficiently treatable by recommended antibiotics, the time of antibiotic therapy initiation is critical, as high mortality rates have been observ...
Saved in:
Main Authors: | David Gur (Author), Theodor Chitlaru (Author), Emanuelle Mamroud (Author), Ayelet Zauberman (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disruption of the NlpD lipoprotein of the plague pathogen Yersinia pestis affects iron acquisition and the activity of the twin-arginine translocation system.
by: Avital Tidhar, et al.
Published: (2019) -
In Vitro Screening of a 1280 FDA-Approved Drugs Library against Multidrug-Resistant and Extensively Drug-Resistant Bacteria
by: Lucie Peyclit, et al.
Published: (2022) -
Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni.
by: Gordana Panic, et al.
Published: (2015) -
Onchocerciasis Drug Discovery: In Vitro Evaluation of FDA-Approved Drugs against <i>Onchocerca gutturosa</i> in Gambia
by: Suzanne Gokool, et al.
Published: (2024) -
FDA approved injection drug against schizophrenia
by: article Editorial
Published: (2023)